Harmony Biosciences Holdings, Inc. HRMY Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $899.11M+3.5% | $868.45M+5.1% | $825.94M+6.9% | $772.53M+3.7% | $744.85M+4.2% | ||
| $210.86M+6.3% | $198.34M+7.7% | $184.21M+10.1% | $167.33M+3.7% | $161.33M+2.9% | ||
| $688.25M+2.7% | $670.11M+4.4% | $641.74M+6.0% | $605.19M+3.7% | $583.53M+4.6% | ||
| 76.5%-0.6pp | 77.2%-0.5pp | 77.7%-0.6pp | 78.3%0.0pp | 78.3%+0.3pp | ||
| $224.44M+18.4% | $189.59M+8.8% | $174.33M+20.4% | $144.75M-8.5% | $158.18M+8.5% | ||
| $120.5M+0.8% | $119.51M+1.3% | $117.93M+1.7% | $115.96M+1.4% | $114.39M+3.1% | ||
| $153.8M+0.8% | $152.54M+23.2% | $123.84M+1.0% | $122.62M+5.8% | $115.92M+5.0% | ||
| $498.73M+8.0% | $461.64M+10.9% | $416.1M+8.5% | $383.33M-1.3% | $388.49M+5.8% | ||
| $498.73M+8.0% | $461.64M+10.9% | $416.1M+8.5% | $383.33M-1.3% | $388.49M+5.8% | ||
| $189.52M-9.1% | $208.47M-7.6% | $225.64M+1.7% | $221.86M+13.8% | $195.04M+2.2% | ||
| 21.1%-2.9pp | 24%-3.3pp | 27.3%-1.4pp | 28.7%+2.5pp | 26.2%-0.5pp | ||
| $14.05M-4.1% | $14.65M-4.3% | $15.31M-4.5% | $16.04M-4.5% | $16.8M-4.0% | ||
| -$531K+21.9% | -$680K— | —— | —— | —— | ||
| $197.57M-8.1% | $215.06M-6.7% | $230.46M+2.4% | $225.14M+14.2% | $197.2M+2.8% | ||
| $51.96M-7.8% | $56.38M+25.9% | $44.78M+1.2% | $44.24M-0.5% | $44.48M-4.0% | ||
| $145.62M-8.2% | $158.69M-14.5% | $185.68M+2.6% | $180.9M+18.5% | $152.72M+5.0% | ||
| 16.2%-2.1pp | 18.3%-4.2pp | 22.5%-0.9pp | 23.4%+2.9pp | 20.5%+0.1pp | ||
| $2.49-8.5% | $2.72-14.5% | $3.18+2.6% | $3.10+18.3% | $2.62+4.4% | ||
| $2.53-8.3% | $2.76-14.6% | $3.23+2.2% | $3.16+18.4% | $2.67+4.3% | ||
| 234.5M+0.1% | 234.2M+0.3% | 233.5M+0.3% | 232.9M+0.4% | 232M+0.4% | ||
| 230.3M+0.2% | 229.8M+0.3% | 229.2M+0.3% | 228.5M+0.3% | 227.9M+0.2% | ||
| $144.96M-8.8% | $158.97M-14.3% | $185.53M+2.3% | $181.38M+18.4% | $153.14M+5.2% | ||
| $22.64M+3.3% | $21.92M+6.7% | $20.55M+4.0% | $19.75M+3.1% | $19.16M+3.3% | ||
| -$531K+21.9% | -$680K— | —— | —— | —— | ||
| $899.11M+3.5% | $868.45M+5.1% | $825.94M+6.9% | $772.53M+3.7% | $744.85M+4.2% | ||
| $189.52M-9.1% | $208.47M-7.6% | $225.64M+1.7% | $221.86M+13.8% | $195.04M+2.2% | ||
| $213.38M-8.2% | $232.33M-6.9% | $249.51M+1.5% | $245.73M+12.2% | $218.99M+1.9% | ||
| $213.38M-8.2% | $232.33M-6.9% | $249.51M+1.5% | $245.73M+12.2% | $218.99M+1.9% | ||
| 23.7%-3.0pp | 26.8%-3.5pp | 30.2%-1.6pp | 31.8%+2.4pp | 29.4%-0.7pp | ||
| $189.52M-9.1% | $208.47M-7.6% | $225.64M+1.7% | $221.86M+13.8% | $195.04M+2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s revenue?
- Harmony Biosciences Holdings, Inc. (HRMY) generated $899.1M in revenue over the trailing twelve months, up 20.7% year over year.
- Is Harmony Biosciences Holdings, Inc. profitable?
- Harmony Biosciences Holdings, Inc. reported $145.6M in net income over the trailing twelve months, a 16.2% net margin.
- What are Harmony Biosciences Holdings, Inc.'s profit margins?
- Gross margin is 76.5% and operating margin is 21.1%, with a 16.2% net margin.
- What is Harmony Biosciences Holdings, Inc.'s earnings per share?
- Harmony Biosciences Holdings, Inc.'s diluted EPS over the trailing twelve months is $2.49.
- Where does Harmony Biosciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
